Literature DB >> 26763730

Inflammation in rheumatology in 2015: New tools to tackle inflammatory arthritis.

Charles A Dinarello1, Leo A B Joosten2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763730     DOI: 10.1038/nrrheum.2015.180

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Authors:  Wolfgang Hueber; Bruce E Sands; Steve Lewitzky; Marc Vandemeulebroecke; Walter Reinisch; Peter D R Higgins; Jan Wehkamp; Brian G Feagan; Michael D Yao; Marek Karczewski; Jacek Karczewski; Nicole Pezous; Stephan Bek; Gerard Bruin; Bjoern Mellgard; Claudia Berger; Marco Londei; Arthur P Bertolino; Gervais Tougas; Simon P L Travis
Journal:  Gut       Date:  2012-05-17       Impact factor: 23.059

2.  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

Authors:  Ivona Aksentijevich; Seth L Masters; Polly J Ferguson; Paul Dancey; Joost Frenkel; Annet van Royen-Kerkhoff; Ron Laxer; Ulf Tedgård; Edward W Cowen; Tuyet-Hang Pham; Matthew Booty; Jacob D Estes; Netanya G Sandler; Nicole Plass; Deborah L Stone; Maria L Turner; Suvimol Hill; John A Butman; Rayfel Schneider; Paul Babyn; Hatem I El-Shanti; Elena Pope; Karyl Barron; Xinyu Bing; Arian Laurence; Chyi-Chia R Lee; Dawn Chapelle; Gillian I Clarke; Kamal Ohson; Marc Nicholson; Massimo Gadina; Barbara Yang; Benjamin D Korman; Peter K Gregersen; P Martin van Hagen; A Elisabeth Hak; Marjan Huizing; Proton Rahman; Daniel C Douek; Elaine F Remmers; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra.

Authors:  Tania O Crișan; Maartje C P Cleophas; Marije Oosting; Heidi Lemmers; Helga Toenhake-Dijkstra; Mihai G Netea; Tim L Jansen; Leo A B Joosten
Journal:  Ann Rheum Dis       Date:  2015-02-03       Impact factor: 19.103

4.  Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.

Authors:  Leo A B Joosten; Tania O Crişan; Tania Azam; Maartje C P Cleophas; Marije I Koenders; Frank L van de Veerdonk; Mihai G Netea; Soohyun Kim; Charles A Dinarello
Journal:  Ann Rheum Dis       Date:  2015-07-14       Impact factor: 19.103

5.  Acute-phase protein α1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion.

Authors:  Eileen Frenzel; Sabine Wrenger; Stephan Immenschuh; Rembert Koczulla; Ravi Mahadeva; H Joachim Deeg; Charles A Dinarello; Tobias Welte; A Mario Q Marcondes; Sabina Janciauskiene
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

6.  Secukinumab failure in Crohn's disease: the yeast connection?

Authors:  Jean Frédéric Colombel; Boualem Sendid; Thierry Jouault; Daniel Poulain
Journal:  Gut       Date:  2012-12-11       Impact factor: 23.059

7.  Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

Authors:  Philip J Mease; Iain B McInnes; Bruce Kirkham; Arthur Kavanaugh; Proton Rahman; Désirée van der Heijde; Robert Landewé; Peter Nash; Luminita Pricop; Jiacheng Yuan; Hanno B Richards; Shephard Mpofu
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

8.  Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).

Authors:  Antonio Abbate; Benjamin Wallace Van Tassell; Sanah Christopher; Nayef Antar Abouzaki; Chiara Sonnino; Claudia Oddi; Salvatore Carbone; Ryan David Melchior; Michael Lucas Gambill; Charlotte Susan Roberts; Michael Christopher Kontos; Mary Ann Peberdy; Stefano Toldo; George Wayne Vetrovec; Giuseppe Biondi-Zoccai; Charles Anthony Dinarello
Journal:  Am J Cardiol       Date:  2014-10-13       Impact factor: 2.778

9.  Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.

Authors:  Leo A B Joosten; Mihai G Netea; Eleni Mylona; Marije I Koenders; R K Subbarao Malireddi; Marije Oosting; Rinke Stienstra; Frank L van de Veerdonk; Anton F Stalenhoef; Evangelos J Giamarellos-Bourboulis; Thirumala-Devi Kanneganti; Jos W M van der Meer
Journal:  Arthritis Rheum       Date:  2010-11

10.  Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Iain B McInnes; Philip J Mease; Bruce Kirkham; Arthur Kavanaugh; Christopher T Ritchlin; Proton Rahman; Désirée van der Heijde; Robert Landewé; Philip G Conaghan; Alice B Gottlieb; Hanno Richards; Luminita Pricop; Gregory Ligozio; Manmath Patekar; Shephard Mpofu
Journal:  Lancet       Date:  2015-06-28       Impact factor: 79.321

  10 in total
  6 in total

Review 1.  Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-31

2.  Novel Resolvin D2 Receptor Axis in Infectious Inflammation.

Authors:  Nan Chiang; Xavier de la Rosa; Stephania Libreros; Charles N Serhan
Journal:  J Immunol       Date:  2016-12-19       Impact factor: 5.422

3.  Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.

Authors:  Lauren M F Merlo; Samantha Grabler; James B DuHadaway; Elizabeth Pigott; Kaylend Manley; George C Prendergast; Lisa D Laury-Kleintop; Laura Mandik-Nayak
Journal:  Clin Immunol       Date:  2017-02-20       Impact factor: 3.969

Review 4.  Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology.

Authors:  Jesmond Dalli; Charles N Serhan
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

5.  Caspase-11 Mediates Neutrophil Chemotaxis and Extracellular Trap Formation During Acute Gouty Arthritis Through Alteration of Cofilin Phosphorylation.

Authors:  Kyle Caution; Nicholas Young; Frank Robledo-Avila; Kathrin Krause; Arwa Abu Khweek; Kaitlin Hamilton; Asmaa Badr; Anup Vaidya; Kylene Daily; Hawin Gosu; Midhun N K Anne; Mostafa Eltobgy; Duaa Dakhlallah; Sudha Argwal; Shady Estfanous; Xiaoli Zhang; Santiago Partida-Sanchez; Mikhail A Gavrilin; Wael N Jarjour; Amal O Amer
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

Review 6.  Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages.

Authors:  Norikazu Kiguchi; Daichi Kobayashi; Fumihiro Saika; Shinsuke Matsuzaki; Shiroh Kishioka
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.